UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004732
Receipt number R000005636
Scientific Title Randomized trial of immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation
Date of disclosure of the study information 2010/12/30
Last modified on 2014/06/16 15:10:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized trial of immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation

Acronym

Immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation

Scientific Title

Randomized trial of immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation

Scientific Title:Acronym

Immuno-enhancing enteral nutrition in esophageal cancer patients undergoing chemoradiation

Region

Asia(except Japan)


Condition

Condition

esophageal carcinoma

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

- reduce side effects of chemoradiation
- cytokine levels

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase III


Assessment

Primary outcomes

reduce side effects of chemoradiation

Key secondary outcomes

cytokine levels


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

immuno-enhancing enteral nutrition (Neomune)

Interventions/Control_2

enteral nutrition (Blendera)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

-squamous cell esophageal carcinoma
-sign consent

Key exclusion criteria

-ECOG2 or over
-with organ metastasis
-with other active cancer

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Somkiat Sunpaweravong, MD

Organization

Prince of Songkla University Hospital, Songkla, 90110 Thailand

Division name

Department of Surgery

Zip code


Address

Prince of Songkla University Hospital, Songkla, 90110 Thailand

TEL

6674-429384

Email

susomkia@medicine.psu.ac.th


Public contact

Name of contact person

1st name
Middle name
Last name Somkiat Sunpaweravong, MD

Organization

Prince of Songkla University Hospital, Songkla, 90110 Thailand

Division name

Department of Surgery

Zip code


Address

Prince of Songkla University Hospital, Songkla, 90110 Thailand

TEL

6674-429384

Homepage URL


Email

susomkia@medicine.psu.ac.th


Sponsor or person

Institute

Department of Surgery, Faculty of Medicine, Prince of Songkla University

Institute

Department

Personal name



Funding Source

Organization

Prince of Songkla University Hospital

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

Thailand


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Prince of Songkla University Hospital, Songkla, 90110 Thailand


Other administrative information

Date of disclosure of the study information

2010 Year 12 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2010 Year 07 Month 15 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date

2012 Year 10 Month 01 Day

Date of closure to data entry

2012 Year 10 Month 01 Day

Date trial data considered complete

2012 Year 10 Month 01 Day

Date analysis concluded

2012 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 12 Month 15 Day

Last modified on

2014 Year 06 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005636


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name